Trial Profile

Open-label, Phase IIIb study to evaluate the efficacy and safety of subcutaneous RoACTEMRA monotherapy in patients with severe Rheumatoid Arthritis being treated with a TNF and experiencing a DAS28 ESR 3.2, using a treat to target approach aiming for improved clinical outcomes

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 16 Jun 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

11 May 2016 Status changed from active, no longer recruiting to completed.
23 Jul 2015 Planned number of patients changed from 120 to 160 as reported by United Kingdom Clinical Research Network.
09 Jul 2015 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com